Selective targeting of malignant cells with cytotoxin-folate conjugates.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Journal of drug targeting (Print)

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.3109/10611869409015898PMID 8069588
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Membrane folate-binding proteins are responsible for folate-protein conjugate endocytosis into cultured cells.

  1993cited by this paper
• Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues.

  1992cited by this paper
• A recombinant form of Pseudomonas exotoxin directed at the epidermal growth factor receptor that is cytotoxic without requiring proteolytic processing.

  1992cited by this paper
• Cytotoxicity of momordin-folate conjugates in cultured human cells.

  1992cited by this paper
• The biological chemistry of folate receptors.

  1992cited by this paper
• Evidence that the hydrophobicity of isolated, in situ, and de novo-synthesized native human placental folate receptors is a function of glycosyl-phosphatidylinositol anchoring to membranes.

  1992cited by this paper
• Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis.

  1992cited by this paper
• Folate-binding protein is a marker for ovarian cancer.

  1991cited by this paper
• Membrane transport of natural folates and antifolate compounds in murine L1210 leukemia cells: role of carrier- and receptor-mediated transport systems.

  1991cited by this paper
• Anti-tumor activities of immunotoxins made of monoclonal antibody B3 and various forms of Pseudomonas exotoxin.

  1991cited by this paper
• Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis.

  1991cited by this paper
• The conversion of the human membrane-associated folate binding protein (folate receptor) to the soluble folate binding protein by a membrane-associated metalloprotease.

  1991cited by this paper
• Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein.

  1991cited by this paper
• Receptor-mediated endocytosis of macromolecular conjugates in selective drug delivery.

  1990cited by this paper
• The glycophospholipid-linked folate receptor internalizes folate without entering the clathrin-coated pit endocytic pathway

  1990cited by this paper
• Folate-binding proteins.

  1990cited by this paper
• Role of folate binding proteins in folate metabolism.

  1989cited by this paper
• Complementary DNA for the folate binding protein correctly predicts anchoring to the membrane by glycosyl-phosphatidylinositol.

  1989cited by this paper
• Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance.

  1989cited by this paper
• A human membrane-associated folate binding protein is anchored by a glycosyl-phosphatidylinositol tail.

  1989cited by this paper
• Interleukin 2 receptor-targeted cytotoxicity. Interleukin 2 receptor- mediated action of a diphtheria toxin-related interleukin 2 fusion protein

  1988cited by this paper
• Influence on immunoreactive folate-binding proteins of extracellular folate concentration in cultured human cells.

  1988cited by this paper
• Mediated uptake of folate by a high-affinity binding protein in sublines of L1210 cells adapted to nanomolar concentrations of folate

  1988cited by this paper
• Ribosome‐inactivating proteins up to date

  1986cited by this paper
• Receptor-mediated folate accumulation is regulated by the cellular folate content.

  1986cited by this paper
• Studies of the role of a particulate folate-binding protein in the uptake of 5-methyltetrahydrofolate by cultured human KB cells.

  1985cited by this paper

• Folic acid-hydrophilic polymer coated mesoporous silica nanoparticles target doxorubicin delivery

  2021cites this paper
• Solvent-free synthesis of isoindolo[2,1-c]pyrazolo[1,5-a]quinazoline and pyrazolo[5′,1′:2,3]pyrimido[6,1-a]isoindol derivatives through a one-pot three-component reaction

  2020cites this paper
• Ligand-Targeted Delivery of Photosensitizers for Cancer Treatment

  2020cites this paper
• Molecular recognition, selective targeting, and overcoming gastrointestinal digestion by folic acid–functionalized oral delivery systems in colon cancer

  2020cites this paper
• Ultrabright fluorescent silica nanoparticles for in vivo targeting of xenografted human tumors and cancer cells in zebrafish.

  2019cites this paper
• DERMAL DELIVERY OF DOCETAXEL LOADED NANO LIQUID CRYSTALS FOR THE TREATMENT OF SKIN CANCER

  2019influential citation
• Leukemia-specific delivery of mutant NOTCH1 targeted therapy

  2018cites this paper
• Click-Functionalized SERS Nanoprobes with Improved Labeling Efficiency and Capability for Cancer Cell Imaging.

  2017cites this paper
• Gene Carriers: Design Elements

  2017cites this paper
• Enhanced Polyethylenimine‐Based Delivery of Nucleic Acids

  2017cites this paper
• Receptor-Mediated Drug Delivery

  2016cites this paper
• Characterization and Use of Folate Receptor Isoforms for Targeting of Epithelial and Myeloid Cells

  2016cites this paper
• Folate-conjugated stealth archaeosomes for the targeted delivery of novel antitumoral peptides

  2016cites this paper
• Intracellular Delivery of Proteins and Peptides

  2016cites this paper
• FOLATE CONJUGATES: A BOON IN THE ANTI-CANCER THERAPEUTICS

  2016cites this paper
• Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine*

  2015cites this paper
• Therapeutic Enzyme‐Responsive Nanoparticles for Targeted Delivery and Accumulation in Tumors

  2015cites this paper
• Folic acid-conjugated europium complexes as luminescent probes for selective targeting of cancer cells.

  2015cites this paper
• Phase and Size Controllable Synthesis of NaYbF4 Nanocrystals in Oleic Acid/ Ionic Liquid Two-Phase System for Targeted Fluorescent Imaging of Gastric Cancer

  2013cites this paper
• Development of PIK-75 nanosuspension formulation with enhanced delivery efficiency and cytotoxicity for targeted anti-cancer therapy.

  2013cites this paper
• Controlling the thickness of polymeric shell on magnetic nanoparticles loaded with doxorubicin for targeted delivery and MRI contrast agent

  2012cites this paper
• Folate-linked drugs for the treatment of cancer and inflammatory diseases.

  2012cites this paper
• The Use of Dendrimers to Optimize the Physicochemical and Therapeutic Properties of Drugs

  2012cites this paper
• Nanodelivery strategies in cancer chemotherapy: biological rationale and pharmaceutical perspectives.

  2012cites this paper
• Phosphatidylinositol 3-kinase Inhibitor (PIK75) Containing Surface Functionalized Nanoemulsion for Enhanced Drug Delivery, Cytotoxicity and Pro-apoptotic Activity in Ovarian Cancer Cells

  2012cites this paper
• Folate receptor mediated targeted delivery of ricin entrapped into sterically stabilized liposomes to human epidermoid carcinoma (KB) cells: effect of monensin intercalated into folate-tagged liposomes.

  2011cites this paper
• Folate-decorated succinylchitosan nanoparticles conjugated with doxorubicin for targeted drug delivery.

  2011cites this paper
• Targeted dendrimeric anticancer prodrug: a methotrexate-folic acid-poly(amidoamine) conjugate and a novel, rapid, "one pot" synthetic approach.

  2010cites this paper
• Folate-mediated solid–liquid lipid nanoparticles for paclitaxel-coated poly(ethylene glycol)

  2010cites this paper
• Synthesis and Application of Polymer Stabilized Lanthanide Fluoride Nanoparticles

  2010cites this paper
• Supramolecular Bioconjugates for Protein and Small Drug Delivery

  2010cites this paper
• A versatile fabrication of upconversion nanophosphors with functional-surface tunable ligands

  2010cites this paper
• Synthesis and characterization of folate-PEG-conjugated polysaccharide nanoparticles for potential use as a targeted DNA carrier

  2009cites this paper
• Real time, noninvasive imaging and quantitation of the accumulation of ligand-targeted drugs into receptor-expressing solid tumors.

  2009cites this paper
• Environmentally responsive peptides as anticancer drug carriers.

  2009cites this paper
• Morphological Effects of Folic Acid on H-Ras Transformed Cell Line by Using a Transmission Electron Microscope

  2009cites this paper
• Multimodal-luminescence core-shell nanocomposites for targeted imaging of tumor cells.

  2009cites this paper
• Drug carrier systems for anticancer agents: A review

  2008cites this paper
• Dendrimers in oncology: an expanding horizon.

  2008cites this paper
• Folate-targeted etoposide-encapsulated lipid nanospheres

  2008cites this paper
• Tumour and dendrimers: a review on drug delivery aspects

  2008cites this paper
• Isostructural folate conjugates radiolabeled with the matched pair 99mTc/188Re: a potential strategy for diagnosis and therapy of folate receptor-positive tumors.

  2007cites this paper
• Site directed drug delivery by non-viral mode

  2007cites this paper
• The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform.

  2007cites this paper
• Cancer nanotechnology: engineering multifunctional nanostructures for targeting tumor cells and vasculatures

  2007cites this paper
• New mechanisms of transcriptional regulation of the folate receptor and other genes by steroid Receptors

  2007cites this paper
• Folate Receptor-Targeted Liposomes for Cancer Therapy

  2006cites this paper
• Folate-mediated targeting of polymeric conjugates of gemcitabine.

  2006cites this paper
• Role of folate receptor genes in reproduction and related cancers.

  2006cites this paper
• Detection of folate binding protein with enhanced sensitivity using a functionalized quartz crystal microbalance sensor.

  2006cites this paper
• Issues related to targeted delivery of proteins and peptides

  2006cites this paper
• Detection of cancer markers via nanoparticle-based mass enhancement

  2006cites this paper
• Targeting the alpha-folate receptor with cyclopenta[g]quinazoline-based inhibitors of thymidylate synthase.

  2006cites this paper
• Synthesis and in vitro/in vivo evaluation of novel 99mTc(CO)3-folates.

  2006cites this paper
• Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer.

  2005cites this paper
• Folate-receptor-mediated delivery of InP quantum dots for bioimaging using confocal and two-photon microscopy.

  2005cites this paper
• Targeting the tumor-associated folate receptor with an 111In-DTPA conjugate of pteroic acid.

  2005cites this paper
• Targeted cancer nanotherapy

  2005cites this paper
• Targeting Cancer Cells with DNA-Assembled Dendrimers: A Mix-and-Match Strategy for Cancer

  2005cites this paper
• Modulation of Folate Receptor Beta for Drug Targeting in Acute Myelogenous Leukemia

  2005cites this paper
• Folate conjugated fluorescent silica nanoparticles for labeling neoplastic cells.

  2005cites this paper
• Folate receptor-mediated drug targeting: from therapeutics to diagnostics.

  2005cites this paper
• Folate receptor-targeted drugs for cancer and inflammatory diseases.

  2004cites this paper
• Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy.

  2004cites this paper
• Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential.

  2004cites this paper
• Folate-mediated targeting of T cells to tumors.

  2004cites this paper
• Folate-targeted chemotherapy.

  2004cites this paper
• Specific antitumor targetable beta-cyclodextrin-poly(ethylene glycol)-folic acid drug delivery bioconjugate.

  2004cites this paper
• Preparation of 66Ga- and 68Ga-labeled Ga(III)-deferoxamine-folate as potential folate-receptor-targeted PET radiopharmaceuticals.

  2003cites this paper
• Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results.

  2003cites this paper
• Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivo.

  2003cites this paper
• Synthesis and physicochemical characterization of folate-cyclodextrin bioconjugate for active drug delivery.

  2003cites this paper
• Receptor induction and targeted drug delivery: a new antileukaemia strategy

  2003cites this paper
• The folate receptor as a molecular target for tumor-selective radionuclide delivery.

  2003cites this paper
• Targeted Diagnostic Agent for Ovarian Cancer: Initial Clinical Results

  2003cites this paper
• Oligonucleotide Conjugates as Potential Antisense Drugs with Improved Uptake, Biodistribution, Targeted Delivery, and Mechanism of Action

  2002cites this paper
• Traitement et diagnostic de maladies associees aux macrophages

  2002cites this paper
• Folate-targeted gene transfer in vivo.

  2002cites this paper
• Design and Function of a Dendrimer-Based Therapeutic Nanodevice Targeted to Tumor Cells Through the Folate Receptor

  2002cites this paper
• Folate-mediated delivery of macromolecular anticancer therapeutic agents.

  2002cites this paper
• Synthesis and biological evaluation of EC20: a new folate-derived, (99m)Tc-based radiopharmaceutical.

  2002cites this paper
• Folate-mediated targeting: from diagnostics to drug and gene delivery.

  2001cites this paper
• Synthesis and evaluation of pteroic acid-conjugated nitroheterocyclic phosphoramidates as folate receptor-targeted alkylating agents.

  2001cites this paper
• Targeted drug delivery via the folate receptor.

  2000cites this paper
• Targeted p53 Gene Therapy-Mediated Radiosensitization and Chemosensitization

  2000cites this paper
• Folic Acid Targeting of Protein Conjugates into Ascites Tumour Cells from Ovarian Cancer Patients

  2000cites this paper
• Folate receptor type β is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia

  1999cites this paper
• Expression of folate receptor type alpha in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix.

  1999cites this paper
• Folate-mediated drug delivery : Effect of alternative conjugation chemistry

  1999cites this paper
• Complete Mapping of Divergent Amino Acids Responsible for Differential Ligand Binding of Folate Receptors α and β*

  1999cites this paper
• Receptor- and Carrier-Mediated Transport Systems for Folates and Antifolates

  1999cites this paper
• Recent advances in the understanding of the mechanism of membrane transport of folates and antifolates.

  1999cites this paper
• Folate copolymer-mediated transfection of cultured cells.

  1999cites this paper
• Folate-mediated drug delivery: effect of alternative conjugation chemistry.

  1999cites this paper
• Structure and regulation of a polymorphic gene encoding folate receptor type gamma/gamma'.

  1998cites this paper
• Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells.

  1998cites this paper
• Lingand transport through cellular matrices and the role of receptor-mediated trafficking

  1998cites this paper
• Folate-mediated targeting of therapeutic and imaging agents to cancers.

  1998cites this paper
• Targeting tumor cells with bispecific antibodies and T cells.

  1998cites this paper
• Identification of amino acid residues that determine the differential ligand specificities of folate receptors alpha and beta.

  1997cites this paper